Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitragynine Attenuates Withdrawal Syndrome in Morphine-Withdrawn Zebrafish
Beng-Siang Khor, Mohd Fadzly Amar Jamil, Mohamad Ilham Adenan, et al.
PLoS ONE (2011) Vol. 6, Iss. 12, pp. e28340-e28340
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction
Zurina Hassan, Muzaimi Mustapha, Visweswaran Navaratnam, et al.
Neuroscience & Biobehavioral Reviews (2012) Vol. 37, Iss. 2, pp. 138-151
Closed Access | Times Cited: 343
Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
Eduardo Cinosi, Giovanni Martinotti, Pierluigi Simonato, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 194
ZebraZoom: an automated program for high-throughput behavioral analysis and categorization
Olivier Mirat, Jenna R. Sternberg, Kristen E. Severi, et al.
Frontiers in Neural Circuits (2013) Vol. 7
Open Access | Times Cited: 126
Zebrafish neurobehavioral phenomics for aquatic neuropharmacology and toxicology research
Allan V. Kalueff, David J. Echevarria, Sumit Homechaudhuri, et al.
Aquatic Toxicology (2015) Vol. 170, pp. 297-309
Closed Access | Times Cited: 113
Reduction in activity by noxious chemical stimulation is ameliorated by immersion in analgesic drugs in zebrafish
Javier López-Luna, Qussay Al-Jubouri, Waleed Al‐Nuaimy, et al.
Journal of Experimental Biology (2017) Vol. 220, Iss. 8, pp. 1451-1458
Open Access | Times Cited: 112
Neurobiology of Kratom and its main alkaloid mitragynine
Farah Wahida Suhaimi, Nurul H.M. Yusoff, Rahimah Hassan, et al.
Brain Research Bulletin (2016) Vol. 126, pp. 29-40
Closed Access | Times Cited: 95
An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116134-116134
Open Access | Times Cited: 9
Social Functioning of Kratom(Mitragyna speciosa)Users in Malaysia
Darshan Singh, Christian P. Müller, Balasingam Vicknasingam, et al.
Journal of Psychoactive Drugs (2015) Vol. 47, Iss. 2, pp. 125-131
Closed Access | Times Cited: 86
Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats
Azadeh Sabetghadam, Surash Ramanathan, Sreenivasan Sasidharan, et al.
Journal of Ethnopharmacology (2013) Vol. 146, Iss. 3, pp. 815-823
Closed Access | Times Cited: 79
Understanding neurobehavioral effects of acute and chronic stress in zebrafish
Konstantin A. Demin, Alexander S. Taranov, Nikita P. Ilyin, et al.
Stress (2020) Vol. 24, Iss. 1, pp. 1-18
Closed Access | Times Cited: 68
Adult zebrafish in CNS disease modeling: a tank that's half-full, not half-empty, and still filling
Darya A. Meshalkina, Elana V. Kysil, Jason E. Warnick, et al.
Lab Animal (2017) Vol. 46, Iss. 10, pp. 378-387
Closed Access | Times Cited: 64
Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
Rahimah Hassan, Pike-See Cheah, Sreenivasan Sasidharan, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 61
Zebrafish models relevant to studying central opioid and endocannabinoid systems
Konstantin A. Demin, Darya A. Meshalkina, Elana V. Kysil, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 86, pp. 301-312
Closed Access | Times Cited: 60
Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal
Lisa Wilson, Soumen Chakraborty, Shainnel O. Eans, et al.
Cellular and Molecular Neurobiology (2021) Vol. 41, Iss. 5, pp. 1131-1143
Open Access | Times Cited: 48
Endogenous opiates and behavior: 2006
Richard J. Bodnar
Peptides (2007) Vol. 28, Iss. 12, pp. 2435-2513
Open Access | Times Cited: 92
Zebrafish models of major depressive disorders
Trehani M. Fonseka, Xiao‐Yan Wen, Jane A. Foster, et al.
Journal of Neuroscience Research (2015) Vol. 94, Iss. 1, pp. 3-14
Closed Access | Times Cited: 62
Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats
Ammar Imad Hazim, Surash Ramanathan, Suhanya Parthasarathy, et al.
The Journal of Physiological Sciences (2014) Vol. 64, Iss. 3, pp. 161-169
Open Access | Times Cited: 56
Development of an opioid self-administration assay to study drug seeking in zebrafish
Gabriel D. Bossé, Randall T. Peterson
Behavioural Brain Research (2017) Vol. 335, pp. 158-166
Closed Access | Times Cited: 54
An Automated Assay System to Study Novel Tank Induced Anxiety
Sara Haghani, Maharshee Karia, Ruey‐Kuang Cheng, et al.
Frontiers in Behavioral Neuroscience (2019) Vol. 13
Open Access | Times Cited: 48
Opioid Neurobiology, Neurogenetics and Neuropharmacology in Zebrafish
Wandong Bao, Andrey D. Volgin, Erik T. Alpyshov, et al.
Neuroscience (2019) Vol. 404, pp. 218-232
Closed Access | Times Cited: 45
In vitro and in vivo pharmacology of kratom
Takato Hiranita, Samuel Obeng, Abhisheak Sharma, et al.
Advances in pharmacology (2022), pp. 35-76
Closed Access | Times Cited: 23
Orally Active Opioid Compounds from a Non-Poppy Source
Robert B. Raffa, Jaclyn R. Beckett, Vivek N. Brahmbhatt, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 12, pp. 4840-4848
Closed Access | Times Cited: 45
Zebrafish models: do we have valid paradigms for depression?
Murilo S. de Abreu, Ashton J. Friend, Konstantin A. Demin, et al.
Journal of Pharmacological and Toxicological Methods (2018) Vol. 94, pp. 16-22
Closed Access | Times Cited: 38
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 1
Open Access | Times Cited: 32
Cognitive and physiological impacts of psychotherapy incorporating human-equine interactions during substance withdrawal: A scoping review
Molly Friend, Molly Nicodemus, C.A. Cavinder, et al.
Journal of Equine Rehabilitation (2025), pp. 100022-100022
Open Access
Page 1 - Next Page

Scroll to top